Scott D. Ramsey
Ph.D., University of Pennsylvania, 1994.
M.D., University of Iowa, 1990.
B.S., University of Iowa, 1983.
Health Related Quality of Life
Internship and Residency in Internal Medicine
A Retrospective Evaluation of Patterns of Care for American Indian and Alaska Native Men with Elevated Prostate Specific Antigen
Linking Cancer Registries with Medicaid to Measure Cancer Treatment and Outcomes
Promoting Cancer Screening Among American Indians through Art and Storytelling
Physician and Navigator Discussion Guides in Prostate Cancer: A Controlled Trial
A Study of Cancer Diagnosis as a Risk Factor for Personal Bankruptcy
Blood Product Use among Persons with Myelodysplastic Syndrome
American College of Physicians
American Society of Clinical Oncology
Cancer Intervention and Surveillance Network
International Health Economics Association
International Society for Pharmacoeconomic and Outcomes Research
Society for Medical Decision Making
Honors and Awards
1997-1998, Howard Temin Career Development Award, National Cancer Institute
1996-1997, Robert Wood Johnson Faculty Support Award, University of Washington
1995-1996, Robert H. Williams Award, American Federation for Clinical Research
1994-1995, Cecile Lehman Mayer Research Award recipient, American College of Chest Physicians
1991-1992, John and Oral Sebelin Award - Outstanding Student in Internal Medicine, College of Medicine, University of Iowa
1989-1990, University Research Foundation support grant, Wharton School, University of Pennsylvania
1987-1988, Dean's Scholarship, Wharton School, University of Pennsylvania
1986-1987, Kellogg Washington Health Policy Fellowship, Wharton School, University of Pennsylvania
1983-1984, University of Iowa Certificate of Achievement, University of Iowa
1982-1983, Chester A. Phillips Scholarship, College of Medicine, University of Iowa
1982-1983, Mortar Board, University of Iowa, University of Iowa
1982-1983, Omicron Delta Kappa, Omicron Delta Kappa--national leadership society,, University of Iowa
1982-1983, BeBeta Gamma Sigma, Beta Gamma Sigma--honorary fraternity in business, University of Iowa
1980-1981, University of Iowa Merit Award, College of Medicine, University of Iowa
2001-2006, Associate Professor, University of Washington, School of Medicine, Medicine, General Internal Medicine
2000-2005, Associate Member, Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Public Health Sciences
1997-2000, Assistant Professor, University of Washington, School of Medicine, Medicine, General Internal Medicine
1997-2000, Assistant Professor, University of Washington, School of Public Health and Community Medicine, Health Services
1997-2000, Joint Assistant Member, Fred Hutchinson Cancer Research Center, Public Health Sciences Division
1995-1998, Staff Physician, VA Puget Sound Health Care System, Seattle Divison
1995-1997, Acting Assistant Professor, University of Washington, Health Sciences
1995-2000, Director, University of Washington, Center for Cost and Outcomes Research, Clinical Economics
1995-1997, Acting Assistant Professor, University of Washington, School of Medicine, Medicine, General Internal Medicine
1994-1995, Chief Medical Resident, University of Washington, Medical Center, Medicine
1994-1995, Acting Instructor, University of Washington, School of Medicine, Medicine
1993-1994, Fellow, University of Washington, School of Medicine, Medicine, General Internal Medicine
1990-1993, University of Washington, Internal Medicine
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients.. Future oncology (London, England).. 2016.
Cancer Stage in American Indians and Alaska Natives Enrolled in Medicaid.. American journal of preventive medicine.. 2016.
Development and Evaluation of an Approach to Using Value of Information Analyses for Real-Time Prioritization Decisions Within SWOG, a Large Cancer Clinical Trials Cooperative Group.. Medical decision making : an international journal of the Society for Medical Decision Making.. 2016.
Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 19(2):218-25.. 2016.
Computed Tomography Screening for Lung Cancer: A High-Value Proposition? JAMA. 315(1):77-8.. 2016.
Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016.
Cancer Prevention: Obstacles, Challenges and the Road Ahead.. Journal of the National Cancer Institute. 108(2). 2016.
Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials.. Journal of the National Cancer Institute. 108(2). 2016.
What Happens When Imatinib Goes Generic? Journal of the National Comprehensive Cancer Network : JNCCN. 14(2):128-31.. 2016.
The Authors Respond.. Journal of managed care & specialty pharmacy. 21(9):844.. 2015.
Cancer-directed therapy and hospice care for metastatic cancer in American Indians and Alaska Natives.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2015.
Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 18(2):161-72.. 2015.
Baseline Estimates of Adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely Initiative Among Patients With Cancer Enrolled With a Large Regional Commercial Health Insurer.. Journal of oncology practice / American Society of Clinical Oncology.. 2015.
Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare.. Journal of oncology practice / American Society of Clinical Oncology. 11(4):267-72.. 2015.
Health care costs among renal cancer patients using pazopanib and sunitinib.. Journal of managed care & specialty pharmacy. 21(1):37-44,44a-d.. 2015.
Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response.. Breast (Edinburgh, Scotland). 24(1):3-11.. 2015.
How state and federal policies as well as advances in genome science contribute to the high cost of cancer drugs.. Health affairs (Project Hope). 34(4):571-5.. 2015.
Design, implementation, and first-year outcomes of a value-based drug formulary.. Journal of managed care & specialty pharmacy. 21(4):269-75.. 2015.
An Economic Evaluation of Home Versus Laboratory-Based Diagnosis of Obstructive Sleep Apnea.. Sleep. 38(7):1027-37.. 2015.
Health Care Costs Among Renal Cancer Patients Using Pazopanib and Sunitinib Response. Journal of Managed Care & Specialty Pharmacy. 21(9):843-843.. 2015.